Central bank invalidates Nor Horizon’s license

YEREVAN, June 2. /ARKA/.  The Management Board of the Central Bank of Armenia (CBA) said today it has invalidated the license that was awarded to Nor Horizon universal credit organization.

According to the press service of the Central Bank, the license was invalidated due to a set of violations of the legislation regulating the activities of credit organizations committed by the organization.

The license had been awarded to the organization in 2006. Nor Horizon LLC was founded by Horizon Foundation, which owned 86% of its shares.

The foundation was established in 2002 to help overcome poverty in Armenia, develop SMEs, and improve access to financial services in remote and border areas. Its founders were the OXFAM, the Kapan Business Support Center, and the HASK-96 public association. -0-

spot_img

POPULAR

Acba Bank has issued over 1 million cards, solidifying its leadership in Armenia

YEREVAN, August 17. /ARKA/. For more than five years, Acba Bank has held the top spot in the Armenian card market. As of May 2026, the total number of cards issued by the bank surpassed 1 million, as reported by the bank's press service.

US dollar, euro, and ruble drop against Armenian dram

YEREVAN, August 18. /ARKA/. The average market exchange rate for the US dollar against the Armenian dram on the Armenian foreign exchange market as of August 18, 2026, fell by 0.25 points to 365.25 drams compared to August 17.

New requirements for banks to manage risks of circumventing international sanctions come into effect in Armenia

YEREVAN, August 17. /ARКА/. As of August 12, 2026, new regulations for banks regarding the management of risks associated with evading international sanctions have been implemented in Armenia.

Armbanks Weekly Digest: Key Events in Armenia’s Financial Market (August 10-16)

YEREVAN, August 17. /ARKA/. Armenia's financial agenda last week focused on setting up payment and cryptocurrency infrastructure, capital market activity, and the parameters of the next stage of universal health insurance.

Shares of Noubar Afeyan’s Moderna soared 124% on news of a successful cancer vaccine trial

YEREVAN, August 20. /ARKA/. Shares of the biotech company Moderna soared 123.6% at the start of trading in the US on August 19, reaching a peak of $140.77, according to trading data. Shares of the pharmaceutical company Merck also rose 11.6% to $150.85, according to Forbes.ru.

LATEST NEWS

spot_imgspot_imgspot_img